OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review
Christopher Gottschalk, Dawn C. Buse, Michael J. Marmura, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15, pp. 175628642210959-175628642210959
Open Access | Times Cited: 10
Christopher Gottschalk, Dawn C. Buse, Michael J. Marmura, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15, pp. 175628642210959-175628642210959
Open Access | Times Cited: 10
Showing 10 citing articles:
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Edoardo Caronna, Victor J Gallardo, Gabriella Egeo, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-333295
Closed Access | Times Cited: 19
Edoardo Caronna, Victor J Gallardo, Gabriella Egeo, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-333295
Closed Access | Times Cited: 19
Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort
Marta Waliszewska‐Prosół, Marcin Straburzyński, Ewa K. Czapińska-Ciepiela, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Marta Waliszewska‐Prosół, Marcin Straburzyński, Ewa K. Czapińska-Ciepiela, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Monthly Headaches and Severity in Patients on Galcanezumab or Traditional Preventive Migraine Medication: A 24-Month Claims and Electronic Health Records Study
Oralee J. Varnado, Michelle Vu, Gilwan Kim, et al.
Neurology and Therapy (2025)
Open Access
Oralee J. Varnado, Michelle Vu, Gilwan Kim, et al.
Neurology and Therapy (2025)
Open Access
Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
A. López-Bravo, Ane Mínguez‐Olaondo, C. Nieves-Castellanos, et al.
Headache The Journal of Head and Face Pain (2025)
Closed Access
A. López-Bravo, Ane Mínguez‐Olaondo, C. Nieves-Castellanos, et al.
Headache The Journal of Head and Face Pain (2025)
Closed Access
Effect of pain-related sodium channels SCN9A and SCN10A polymorphisms in migraine chronification
Erhan Kilic, Ceyda Colakoglu Bergel, Işıl Ezgi Eryılmaz, et al.
Neurological Research (2025), pp. 1-12
Closed Access
Erhan Kilic, Ceyda Colakoglu Bergel, Işıl Ezgi Eryılmaz, et al.
Neurological Research (2025), pp. 1-12
Closed Access
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
Roberto De Icco, Gloria Vaghi, Marta Allena, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Roberto De Icco, Gloria Vaghi, Marta Allena, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Early Improvements With Atogepant for the Preventive Treatment of Migraine
Richard B. Lipton, Pranav Gandhi, Cristina Tassorelli, et al.
Neurology (2024) Vol. 104, Iss. 2
Closed Access | Times Cited: 2
Richard B. Lipton, Pranav Gandhi, Cristina Tassorelli, et al.
Neurology (2024) Vol. 104, Iss. 2
Closed Access | Times Cited: 2
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection – A Narrative Review
Claudia Altamura, Nicoletta Brunelli, Marilena Marcosano, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 959-971
Open Access | Times Cited: 4
Claudia Altamura, Nicoletta Brunelli, Marilena Marcosano, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 959-971
Open Access | Times Cited: 4
Fremanezumab in real-life clinical practice: specialized headache center experience
Yu. É. Azimova, K. V. Skorobogatikh, V. В. Osipova, et al.
Neurology neuropsychiatry Psychosomatics (2024) Vol. 16, Iss. 3, pp. 72-78
Open Access
Yu. É. Azimova, K. V. Skorobogatikh, V. В. Osipova, et al.
Neurology neuropsychiatry Psychosomatics (2024) Vol. 16, Iss. 3, pp. 72-78
Open Access
The Neurologist’s Guide to Drug Pricing in the United States
Kavita Nair, Jonathan D. Santoro
CONTINUUM Lifelong Learning in Neurology (2024) Vol. 30, Iss. 4, pp. 1259-1271
Closed Access
Kavita Nair, Jonathan D. Santoro
CONTINUUM Lifelong Learning in Neurology (2024) Vol. 30, Iss. 4, pp. 1259-1271
Closed Access
The importance of an early onset of migraine preventive disease control: A roundtable discussion
Christopher Gottschalk, Anirban Basu, Andrew Blumenfeld, et al.
Cephalalgia Reports (2022) Vol. 5, pp. 251581632211345-251581632211345
Open Access | Times Cited: 2
Christopher Gottschalk, Anirban Basu, Andrew Blumenfeld, et al.
Cephalalgia Reports (2022) Vol. 5, pp. 251581632211345-251581632211345
Open Access | Times Cited: 2
